A Prospective Study of Madecassoside Tablets in Sclerotic Chronic Graft-versus-Host Disease After Allo-HSCT

Clinical trial NCT07606703 · RECRUITING

Trial details

NCT number: NCT07606703
Sponsor: WeiShi
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Graft-Versus-Host Disease Graft vs Host Disease

Start date: 2025-09-01
Primary completion: 2028-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.